Know Cancer

or
forgot password


Phase 2
18 Years
90 Years
Open (Enrolling)
Female
Breast Cancer

Thank you

Trial Information


Inclusion Criteria:



- Patients with recurrent or metastatic breast cancer

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Principal Investigator

Leonard R. Prosnitz, M.D.

Investigator Role:

Principal Investigator

Authority:

United States: Federal Government

Study ID:

NCRR-M01RR00030-0156

NCT ID:

NCT00006433

Start Date:

January 2000

Completion Date:

Related Keywords:

  • Breast Cancer
  • Breast Neoplasms

Name

Location

Radiation Oncology, Duke University Medical CenterDurham, North Carolina  21170